Xiaoyang Sun
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
The role of irregular eating behaviors in metabolic dysfunction-associated steatotic liver disease: evidence from a multicenter cross-sectional study in China.
Journal: Journal of translational medicine
Published: March 25, 2025
Association Between Free Triiodothyronine and Diabetic Peripheral Neuropathy in Euthyroid Patients With Type 2 Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 02, 2024
Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway.
Journal: Journal of hepatology
Published: June 23, 2024
Intermittent compared with continuous calorie restriction for treatment of metabolic dysfunction-associated steatotic liver disease: a randomized clinical trial.
Journal: The American journal of clinical nutrition
Published: June 16, 2024
Increased serum β-hydroxybutyrate/acetoacetate ratio and aggravated histological liver inflammation in females with metabolic dysfunction-associated steatotic liver disease and polycystic ovary syndrome.
Journal: Journal of molecular cell biology
Published: May 03, 2024
Association of vitamin D deficiency and subclinical diabetic peripheral neuropathy in type 2 diabetes patients.
Journal: Frontiers in endocrinology
Published: December 12, 2023
Association between fast eating speed and metabolic dysfunction-associated steatotic liver disease: a multicenter cross-sectional study and meta-analysis.
Journal: Nutrition & diabetes
Published: December 03, 2023
Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolism.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 30, 2023
Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression.
Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression.
Journal: Hepatology (Baltimore, Md.)
Published: September 13, 2022
A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease.
Journal: Diabetes/metabolism research and reviews
Published: April 24, 2022
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease.
Journal: Diabetes & metabolism
Published: March 08, 2022
Last Updated: 09/26/2026